ECAU Opinions 08/11/2014 19:34:48 $ECAU Dilution appeared

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
ECAU Opinions 08/11/2014 19:34:48 $ECAU
Dilution appeared to be done early so I don't expect anymore tomorrow. Either way, you right....MOMO is huge. I would not be surprised at all to see a gap up tomorrow and close in on .01

GL

ECAU
$ECAU, IF WE DO ANOTHER 200+ MIL TOMORROW .0075-.009,,,,
IF THERE IS DILUTION LOWER THAN TODAYS CLOSE.
WITH NEWS .015+.

I EXPECT NEWS THIS WEEK WITH ALL BIGGER PLAYERS HERE TODAY.
GOOD LUCK.

1 THING FOR SURE/THIS IS NOT A STOCK TO FLIP RIGHT NOW.
THE MOMO IS HUGE.
I SEE A GAP AT OPEN TO AT LEAST .0047+ TOMORROW.
$ECAU, Strategic Advantages,,,,,,,,,,,,,,,,,,,,,,,,,,,,

Short Term ROI

While other solutions claim a possible ROI in 6 years or more, EchoDrive targets a payback of 24 months or less, without the need for rich subsidies.

Modular Battery Pack

Our modular battery pack allows fleets to deploy just the amount of expensive batteries needed on each vehicle to shorten the payback period.

Ability to Rapidly Scale

By leveraging mostly off-the-shelf components from industry leading automotive suppliers, EchoDrive can scale to delivering hundreds-of-thousands of kits without manufacturing risk.


Broad Vehicle Deployment

Complete retrofit kits and new vehicles take significant design and regulatory approval. EchoDrive can be fitted on many vehicle models with adapter plates and brackets.

Low Risk to Fleet Operations

In the unlikely event of a component failure, the vehicle will simply revert to its pre-conversion operating capabilities. This eliminates the fear of unproven new technologies affecting operations. Predictable vehicle resale value.

New Financing Options

Because of EchoDrive's short ROI, shared savings models and preapproved financing options allow cash-poor companies to benefit from day one.


Where do you suspect the PPS to be in the next few days?
$ECAU, EchoDrive is a revolutionary cost-reduction platform for converting fleet vehicles into highly fuel-efficient plug-in hybrids. For the first time, fleet operators have an option to significantly reduce their operating expenses

with a low risk and cost effective solution where the 'real-world' payback can be 24-36 months or less. EchoDrive can be easily bolted onto new and existing vehicles cost-effectively, for the purpose of substantially reducing a fleet vehicle's operating cost.


EchoDrive, a revolutionary patent-pending cost-reduction solution for converting fleet vehicles into highly fuel-efficient plug-in hybrids. EchoDrive can be easily bolted onto new and existing vehicles cost-effectively, for the purpose of substantially reducing a vehicle's fuel consumption. For the first time, fleet operators have an option that allows them to significantly reduce their fuel expenses with a solution that makes both short term as well as long term economic sense.



Very possible.
Accumulation is crazy, RSI is super low.

I don't see how this doesn't hit .01 tomorrow.
Huge day here.. Reloaded, should see dip and ripp again tomorrow

ECAU
You are reading it correctly. The party is just starting.
Great day! This will be back in 0.02+ any day. Load and hold!
Hmm. Maybe I should get in$$$

-Pier
RSI at 29, amazing
Finally got some time and checking out the action here, overall it seems the trend fared well today, if it were a PnD there would be the characteristic dramatic drop near EOD, in which you could tell completely what was going on by the L2 trades, which we did not have here. The dilution was minimal imho, VFIN was there so was BMAK, but most of the sells came from flippers, day traders and groups. We are set-up perfectly chartwise for a continuance, in addition I do believe that management diluted this down the last few months to more than likely buy in at these levels for an attempted upcoming PR that could blow through the roof.

I've seen this in the past MULTIPLE times, where the PPS was driven into the ground and then pumped sky high with relentless buying for no reason, then BAM PR after PR after PR.

Also look at the Accum/Distri...Enough said.

This is what I think is happening here and I locked and loaded for the ride.

GLTA! Looking forward to the rest of the week :]

- The Wiz
added 75 Board marks, 7 of ihubs top traders in today. Big day coming tomorrow. Follow the money
Cool...thanks Trader53!

52wk is .58!!!

$ECAU
I agree fully; tomorrow we will see a nice continuation of this reversal. We had plenty of churning and profit taking today, healthy for the multi-day run as I see it. Open .0044 area and run north of .007 tomorrow imo
There were millions and millions and millions shares bought between 0039-0055 today! IMO most people who bought between 0018-0039 today took some type of profits today! With that being said the RSI and charts only pointing towards up and the volume should be over 100million tomorrow we will have a huge green day tomorrow
Major sell off coming get out asap
BMAK and VFIN diluting this junk back down to .001!!!!!!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 91

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
Extreme Weather Survivors Rally for Change with 'Stolen Summers'

Updated Category News Views 70

Lighting a Fire Under Complacency Elections often bring out the big dogs, but rarely do you see a grassroots campaign like Extreme Weather Survivors’ 'Stolen Summers' making such ripples. Rallying from New York to North Carolina and everywhere in between, this campaign has been a clarion call for communities ravaged by Mother Nature's fury. And let's face it, the...

Continue Reading
Steven Johnson Boosts Latham's Tax Team in D.C.

Updated Category News Views 120

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 120

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
TETRA Hits High Mark with Robust Q3 Earnings Surge

Updated Category News Views 98

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 49

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Boston Scientific's SIMPLAAFY Trial Promises Post-Op Ease

Updated Category News Views 137

SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...

Continue Reading
MIAX Preps New Binary Options Amid SEC Filings

Updated Category News Views 50

MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 28

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Platinum Equity's Bold Move on Warren Valve: An Analysis

Updated Category News Views 127

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Continue Reading

Top 5 Most Recently Viewed Articles

Alleima Deepens Ties with Airbus, Reinforces Strategy

Updated Category News Views 27

A Cemented Alliance in Aerospace It ain't every day you see a partnership like this get fortified. Alleima, the Swedish heavyweight in metal solutions, is securing its bond with aviation giant Airbus. This isn’t some flash-in-the-pan fling; this is about titanium seamless tubes powering those shiny flying machines and elevating the aerospace game. The Backbone of a...

Continue Reading
Important Update for Sable Offshore Investors on Class Action

Updated Category News Views 192

Important Update for Sable Offshore Investors Sable Offshore Corp. (SOC), a prominent player in the oil transportation industry, is currently entangled in legal proceedings that have implications for its investors. If you've invested in SOC and suffered losses exceeding $100,000, there are critical updates you need to be aware of. Details on the Class Action Lawsuit A...

Continue Reading
Srini Rajamani Takes Helm as CEO, Shaping Future of Opus Technologies

Updated Category News Views 362

Srini Rajamani Appointed as CEO of Opus Technologies Opus Technologies, a pioneer in payment solutions, has announced the leadership transition to Srini Rajamani as the new Chief Executive Officer. His appointment becomes effective immediately, succeeding Praveen TM, who will remain an integral part of the leadership team. Innovative Leadership and Experience Srini...

Continue Reading
PacBio Partners with NCCS for Enhanced Cancer Research Efforts

Updated Category News Views 103

PacBio's New Collaboration for Cancer Research Pacific Biosciences (NASDAQ: PACB), commonly referred to as PacBio, has recently entered an exciting partnership with the National Cancer Centre Singapore (NCCS). This Research Collaboration Agreement (RCA) aims to push the boundaries of cancer research in Asia, utilizing state-of-the-art sequencing technologies. Innovative...

Continue Reading
Oriental Rise Holding Limited Completes Successful IPO Journey

Updated Category News Views 82

Oriental Rise Holding Limited Celebrates IPO Success Ningde, China - Oriental Rise Holding Limited, also known simply as "Oriental Rise" (NASDAQ: ORIS), has marked a momentous event in its journey by successfully closing its initial public offering (IPO). The offering, which involved 1,750,000 ordinary shares priced at $4 each, demonstrates the growing interest in the...

Continue Reading